Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Liberty All-Star Equity Fund
USA
$1.79B
| $14.3M | ﹤0.01% |
2,497,333
-306,417
| -11% | -$1.66M |
|
1652
Silicon Motion
SIMO
$8.6B
| $14.3M | ﹤0.01% |
292,576
-145,714
| -33% | -$6.46M |
|
|
HRC
1653
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $14.3M | ﹤0.01% |
129,964
-28,900
| -18% | -$3.03M |
|
1654
Coherent
COHR
$51.4B
| $14.3M | ﹤0.01% |
301,989
+114,401
| +61% | +$4.54M |
|
1655
Polaris
PII
$3.82B
| $14.3M | ﹤0.01% |
154,033
-209,963
| -58% | -$16M |
|
1656
Watsco Inc
WSO
$12.7B
| $14.3M | ﹤0.01% |
80,203
-5,169
| -6% | -$855K |
|
|
CS
1657
DELISTED
Credit Suisse Group
CS
| $14.2M | ﹤0.01% |
1,381,389
-699,034
| -34% | -$6.28M |
|
|
CLLS
1658
Cellectis
CLLS
$277M
| $14.2M | ﹤0.01% |
799,636
+78,292
| +11% | +$1.19M |
|
1659
Insmed
INSM
$21.4B
| $14.2M | ﹤0.01% |
516,387
-230
| -0% | -$5.45K |
|
1660
WisdomTree US High Dividend Fund
DHS
$1.56B
| $14.2M | ﹤0.01% |
227,884
-8,051
| -3% | -$495K |
|
1661
Prosperity Bancshares
PB
$8.97B
| $14.2M | ﹤0.01% |
239,007
+78,662
| +49% | +$4.54M |
|
1662
Progyny
PGNY
$2.44B
| $14.2M | ﹤0.01% |
549,767
+502,636
| +1,066% | +$11.5M |
|
|
EFT
1663
Eaton Vance Floating-Rate Income Trust
EFT
$283M
| $14.2M | ﹤0.01% |
1,242,434
+231,964
| +23% | +$2.55M |
|
|
HEP
1664
DELISTED
Holly Energy Partners, L.P.
HEP
| $14.2M | ﹤0.01% |
970,648
+205,136
| +27% | +$3.01M |
|
1665
iShares Core US REIT ETF
USRT
$4.62B
| $14.2M | ﹤0.01% |
325,647
+148,882
| +84% | +$6.25M |
|
1666
Franklin Resources
BEN
$17.6B
| $14.1M | ﹤0.01% |
672,253
-586,718
| -47% | -$11.1M |
|
|
RETA
1667
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $14.1M | ﹤0.01% |
90,293
-24,571
| -21% | -$3.74M |
|
1668
Cenovus Energy
CVE
$55.7B
| $14.1M | ﹤0.01% |
3,009,200
-6,288,125
| -68% | -$24.2M |
|
1669
Lennox International
LII
$14.4B
| $14M | ﹤0.01% |
60,249
+44,666
| +287% | +$9.02M |
|
|
BMY.RT
1670
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $14M | ﹤0.01% |
3,913,446
-1,773,285
| -31% | -$6.4M |
|
1671
Community Bank
CBU
$3.41B
| $13.9M | ﹤0.01% |
244,352
+44,678
| +22% | +$2.63M |
|
1672
Pinnacle West Capital
PNW
$12.2B
| $13.9M | ﹤0.01% |
190,100
-86,751
| -31% | -$6.55M |
|
1673
NeoGenomics
NEO
$1.96B
| $13.9M | ﹤0.01% |
449,518
-63,792
| -12% | -$1.77M |
|
1674
Ambarella
AMBA
$3.77B
| $13.9M | ﹤0.01% |
303,485
-429,190
| -59% | -$22.1M |
|
1675
WD-40
WDFC
$3.05B
| $13.9M | ﹤0.01% |
69,960
-780
| -1% | -$142K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.